Ki Summary

Reaction Details

Report a problem with these data

Target

Apelin receptor

Ligand

BDBM269852

Substrate/Competitor

n/a

Meas. Tech.

[35S]GTPgammaS Binding Assay

EC50

0.570±n/a nM

Citation

Chen, N; Chen, X; Chen, Y; Cheng, AC; Connors, RV; Deignan, J; Dransfield, PJ; Du, X; Fu, Z; Heath, JA; Horne, DB; Houze, J; Kaller, MR; Khakoo, AY; Kopecky, DJ; Lai, S; Ma, Z; McGee, LR; Medina, JC; Mihalic, JT; Nishimura, N; Olson, SH; Pattaropong, V; Swaminath, G; Wang, X; Yang, K; Yeh, W; Debenedetto, MV; Farrell, RP; Hedley, SJ; Judd, TC; Kayser, F Triazole agonists of the APJ receptor US Patent US10221162 Publication Date 3/5/2019

More Info.:

Get all data from this article, Assay Method

Apelin receptor

Name:

Apelin receptor

Synonyms:

Type:

Enzyme Catalytic Domain

Mol. Mass.:

42664.06

Organism:

Homo sapiens (Human)

Description:

P35414

Residue:

380

Sequence:

MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRSSREK
RRSADIFIASLAVADLTFVVTLPLWATYTYRDYDWPFGTFFCKLSSYLIFVNMYASVFCL
TGLSFDRYLAIVRPVANARLRLRVSGAVATAVLWVLAALLAMPVMVLRTTGDLENTTKVQ
CYMDYSMVATVSSEWAWEVGLGVSSTTVGFVVPFTIMLTCYFFIAQTIAGHFRKERIEGL
RKRRRLLSIIVVLVVTFALCWMPYHLVKTLYMLGSLLHWPCDFDLFLMNIFPYCTCISYV
NSCLNPFLYAFFDPRFRQACTSMLCCGQSRCAGTSHSSSGEKSASYSSGHSQGPGPNMGK
GGEQMHEKSIPYSQETLVVD

BDBM269852

n/a

Name

BDBM269852

Synonyms:

(1R,2S)-1-amino-N-(4-(2,6-dimethoxyphenyl)-5-(6-methoxypyridin-2-yl)-4H-1,2,4-triazol-3-yl)-1-(5-methylpyrimidin-2-yl)propane-2-sulfonamide or (1R,2R)-1-amino-N-(4-(2,6-dimethoxyphenyl)-5-(6-methoxypyridin-2-yl)-4H-1,2,4-triazol-3-yl)-1-(5-methylpyrimidin-2-yl)propane-2-sulfonamide or (1S,2S)-1-amino-N-(4-(2,6-dimethoxyphenyl)-5-(6-methoxypyridin-2-yl)-4H-1,2,4-triazol-3-yl)-1-(5-methylpyrimidin-2-yl)propane-2-sulfonamide | US10058550, Example 376.0 | US10058550, Example 377.0 | US10058550, Example 378.0 | US10058550, Example 379.0 | US10221162, Example 379.0 | US9845310, Example 379.0

Type

Small organic molecule

Emp. Form.

C24H28N8O5S

Mol. Mass.

540.595

SMILES

COc1cccc(n1)-c1nnc(NS(=O)(=O)[C@H](C)[C@H](N)c2ncc(C)cn2)n1-c1c(OC)cccc1OC |r,wU:18.19,wD:16.17,(-8.84,-11.47,;-7.35,-11.86,;-6.95,-13.35,;-8.04,-14.44,;-7.64,-15.93,;-6.15,-16.33,;-5.06,-15.24,;-5.46,-13.75,;-3.58,-15.64,;-3.1,-17.1,;-1.56,-17.1,;-1.09,-15.64,;.25,-14.87,;1.58,-15.64,;.81,-16.97,;2.35,-16.97,;2.92,-14.87,;2.92,-13.33,;4.25,-15.64,;4.25,-17.18,;5.58,-14.87,;6.92,-15.64,;8.25,-14.87,;8.25,-13.33,;9.58,-12.56,;6.92,-12.56,;5.58,-13.33,;-2.33,-14.73,;-2.33,-13.19,;-3.67,-12.42,;-5,-13.19,;-6.33,-12.42,;-3.67,-10.88,;-2.33,-10.11,;-1,-10.88,;-1,-12.42,;.34,-13.19,;1.67,-12.42,)|

Structure